Stay updated on Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page.

Latest updates to the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedRevision history shows the addition of version v3.3.2 and the removal of version v3.2.0 in the page's record history, which are minor metadata updates that do not affect study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the site-wide government funding and operating status notice that previously appeared at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check34 days agoChange DetectedThe latest version shows a UI refresh of the Record History page with no changes to core trial data (status, enrollment, or outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now shows a newer date and indicates results are posted, adding detailed Outcome Measures and Results (from 2025-09-18) while removing the previous status of Results Submitted, signaling a transition from submission to posting.SummaryDifference2%

- Check63 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference11%

- Check70 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.3%

Stay in the know with updates to Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Dosing Regimens in Multiple Myeloma Clinical Trial page.